Pylarify
Ended Awarded Last action
- Contract number
- 36C25523F0097
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 15
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $485,568
Award facts
- Contract value 100% obligated
- $485,568.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Topeka, KS 66622, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$51,669 | |
| Funding Only Action | -$350,000 | |
| Funding Only Action | -$49,722 | |
| Other Administrative Action | $140,000 | |
| Exercise an Option | $400,000 | |
| Original award | $396,959 |
About this award
This is a federal delivery order contract awarded by the Department of Veterans Affairs (VA) to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. and subsidiary of Lantheus Holdings, Inc. The contract is for the delivery of PYLARIFY, a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect and image prostate cancer. The contract has a ceiling value of $485,568.48 and a period of performance through October 21, 2024. The contract was awarded on April 22, 2023 and is a firm fixed price delivery order placed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract is not a set-aside for small businesses. Lantheus Holdings, Inc. is the parent company of Progenics Pharmaceuticals and maintains several significant Indefinite Delivery Vehicles (IDVs) with the VA and Defense Health Agency for the procurement of radiopharmaceuticals and other specialized medical imaging products.
Quick answers
Who was awarded contract 36C25523F0097?
36C25523F0097 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 15 (Veterans Health Administration) on April 22, 2023.
How much is contract 36C25523F0097 worth?
The government has obligated $485,568 on 36C25523F0097.
Is contract 36C25523F0097 an order under another contract?
Yes. 36C25523F0097 is a delivery order under 36F79719D0170, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25523F0097 competed?
The extent of competition for 36C25523F0097 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award